Cogent Biosciences, Inc.

COGT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$125,297$127,598$126,003$98,165
Short-Term Investments$265,593$110,250$119,658$188,912
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$6,354$7,160$7,223$9,395
Total Curr. Assets$397,244$245,008$252,884$296,472
Property Plant & Equip (Net)$23,865$24,947$26,052$26,564
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$4,824$4,862$4,862$4,862
Total NC Assets$28,689$29,809$30,914$31,426
Other Assets$0$0$0$0
Total Assets$425,933$274,817$283,798$327,898
Liabilities
Payables$16,029$16,625$14,154$12,013
Short-Term Debt$1,706$1,658$1,611$1,565
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$44,511$40,139$33,553$42,132
Total Curr. Liab.$62,246$58,422$49,318$55,710
LT Debt$58,853$59,000$15,480$15,902
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,370$2,359$5$0
Total NC Liab.$61,223$61,359$15,485$15,902
Other Liabilities$0$0$0$0
Cap. Leases$16,309$16,709$17,091$17,467
Total Liabilities$123,469$119,781$64,803$71,612
Equity
Pref Stock$107,915$107,915$108,165$110,600
Common Stock$141$114$114$110
Retained Earnings-$1,085,928-$1,004,998-$931,469-$859,483
AOCI$208$13$164$447
Other Equity$1,280,128$1,051,992$1,042,021$1,004,612
Total Equity$302,464$155,036$218,995$256,286
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$425,933$274,817$283,798$327,898
Net Debt-$64,738-$66,940-$108,912-$80,698
Cogent Biosciences, Inc. (COGT) Financial Statements & Key Stats | AlphaPilot